March 7th 2024
It was found in a recent study that the updated Moderna, Pfizer-BioNTech and Novavax COVID-19 vaccines, when combined with antiviral treatments like nirmatrelvir and molnupiravir, can significantly decrease the chances of hospitalization and death from current COVID-19 variants.
Up to half of patients infected with SARS-CoV-2 may experience symptoms lasting beyond three months post-infection, including severe fatigue, organ system-based symptoms and other persistent symptoms.
Pfizer’s COVID-19 Vaccine Expected to Maintain $37 billion 2022 Sales Into the Future
February 23rd 2023Pfizer's COVID-19 vaccine, Comirnaty, dominated in 2022 with forecast sales of $37 billion. The vaccine is expected to maintain these sales going into the future, with with sales forecasts up by 16%.
Read More
Long COVID Symptoms More Common in Those Infected During Pre-Delta Variant Period
February 20th 2023Up to half of patients infected with SARS-CoV-2 may experience symptoms lasting beyond three months post-infection, including severe fatigue, organ system-based symptoms and other persistent symptoms.
Read More
Case Report Highlights Possible Paxlovid Interaction With Statins
February 20th 2023A 72-year-old man developed worsening myalgia while taking Paxlovid. The FDA and authors of a case report in JAMA Internal Medicine today says patients who would benefit from Paxlovid should be advised to temporarily stop taking statins and other drugs with potentially serious drug-drug interactions with Paxlovid.
Read More
The AMA, AHA and ANA Release PSA Urging Folks to Stay Updated on COVID-19 Vaccines
February 9th 2023Healthcare leaders are urging the public in a new public service announcement to make sure they are up-to-date on their COVID-19 vaccines, including the updated bivalent booster dose when eligible.
Read More
The COVID-19 Public Health Emergency Renews for the 12th Time
January 12th 2023The public health emergency (PHE) has again been renewed for the COVID-19 pandemic as of yesterday by the Biden administration. The announcement was made by the Department of Health and Human Services' (HHS) Secretary Xavier Becerra, which marks it as the 12th renewal.
Read More
Mortality Rates Higher for Medicaid HCBS Recipients During COVID-19
January 11th 2023It was found that excess mortality for this group of people with disabilities was 7.4 times that of community-dwelling Medicaid beneficiaries of the same age who were not receiving home and community-based services, and 26.6 times that of the general population.
Read More
Less Nursing Home Residents, Staff Are Up-to-Date on Covid Vaccinations Amid Winter Surge
December 15th 2022Less than half (45%) of all nursing facility residents and less than a quarter of staff (22%) are up to date with their COVID-19 vaccinations. That is a sharp drop from the 87% of nursing facility residents and staff who completed their primary vaccination series.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
COVID Cases Are Less Harsh, Amid 'Certainly' Still Being in the Middle of a Pandemic
December 11th 2022Dr. Syra Madad of the NYC hospital system and an Infectious Disease Epidemiologist at Harvard's Belfer Center for Science and International Affairs responded to Dr. Anthony Fauci's, director of NIAID, statement made in late November that the U.S. is “certainly” still in the middle of a Covid-19 pandemic.
Read More
COVID-19 Associated With Decreased Sperm Concentration, Study Finds
December 2nd 2022Evidence that COVID-19 might affect male fertility is accumulating, although it is an incomplete picture and there is no final word on the subject. This study found a possible effect on concentration but not on sperm motility or morphology.
Read More
COVID-19 Pandemic Caused Only a Dip in HIV Prevention, Care Services
December 1st 2022Results reported by CDC researchers show a sharp drop-off in HIV prevention and care services, such as preexposure prophylaxis prescriptions, in the second quarter of 2020 but then a rebound in third quarter.
Read More
Findings from a cros-sectional study reported by Yale and Mount Sinai researchers last week in a preprint last week linked long COVID to low levels of cortisol, the stress hormone, and possibly to reactivation of latent Epstein-Barr virus infections. Eric Topol called the study one of the best of long COVID so far.
Read More
Covid-19 Antibodies Found in Nonimmune Blood Cancer Patients After Receiving Booster
August 12th 2022Patients with blood cancers have been reported to have less of a chance to develop immunity from the COVID-19 vaccination. However, new data has been found stating those who have been previously vaccinated with no immunity and then followed up with a booster dose, eventually developed antibodies against the virus.
Read More
Pandemic Mortality Rate Much Lower in Canada Than in the US. Why?
July 13th 2022Some researchers have pointed to the benefits of a single-payer system such as the one in Canada. But the author of the PNAS commentary, David Fisman, say it may be trace back to the more communitarian outlook of Canadians
Read More
The BA.5 Variant Is Now Dominant: What News Outlets, Social Media Are Saying
July 11th 2022White House COVID-19 coordinator Ashish Jha tweeted last week that “we know how to manage this moment.” News coverage and social media posting about the BA.5 variant crested as the variant became the dominant strain circulating in the U.S.
Read More